Home › Funds › TRV GP VI, LLC › RAPP

TRV GP VI, LLC position in RAPP

RAPPORT THERAPEUTICS INC · Health Care

TRV GP VI, LLC reported holding 969,218 shares of RAPP (RAPPORT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$40.4M, representing 17.39% of its reported portfolio and ranking #3 among its reported holdings. TRV GP VI, LLC has disclosed RAPP holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)969.22K sh
Reported value held$40.39M
Portfolio Weight17.39%
First reportedQ4 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TRV GP VI, LLC's RAPP position evolved

TRV GP VI, LLC first disclosed a stake in RAPP in Q4 2024 at 969,218 shares (US$17.2M). The position peaked in Q2 2026 at 969,218 shares, worth US$40.4M. Across 7 filings, TRV GP VI, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 969,218 shares valued at US$40.4M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 969.22K $17.19M New
Q1 2025 969.22K $9.72M Hold
Q2 2025 969.22K $11.02M Hold
Q3 2025 969.22K $28.79M Hold
Q4 2025 969.22K $29.41M Hold
Q1 2026 969.22K $30.33M Hold
Q2 2026 969.22K $40.39M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RAPP and 13F data

RAPP (RAPPORT THERAPEUTICS INC) is a Health Care company. 66 other funds we track also report a position in RAPP — the largest reported positions include TRV GP V, LLC (US$261.7M), ARCH Venture Management, LLC (US$155.4M), Cormorant Asset Management, LP (US$110.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RAPP

All RAPP fund holders →

FAQ

How long has TRV GP VI, LLC held RAPP?

TRV GP VI, LLC has disclosed RAPP holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is TRV GP VI, LLC's current position in RAPP?

As of Q2 2026, TRV GP VI, LLC holds 969.22K shares of RAPP (RAPPORT THERAPEUTICS INC), valued at $40.39M, representing 17.39% of its reported portfolio and ranking #3.

Has TRV GP VI, LLC been buying or selling RAPP?

In the latest 13F filing (Q2 2026), TRV GP VI, LLC held unchanged its position in RAPP. The position peaked in Q2 2026 at 969.22K shares.

Which other funds hold RAPP?

Other major institutional holders of RAPP include TRV GP V, LLC, ARCH Venture Management, LLC, Cormorant Asset Management, LP, among 66 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.